These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6571990)

  • 21. Heterogeneous binding of [3H]4-DAMP to muscarinic cholinergic sites in the rat brain: evidence from membrane binding and autoradiographic studies.
    Araujo DM; Lapchak PA; Quirion R
    Synapse; 1991 Nov; 9(3):165-76. PubMed ID: 1776129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 125I-BW-A844U, an antagonist radioligand with high affinity and selectivity for adenosine A1 receptors, and 125I-azido-BW-A844U, a photoaffinity label.
    Patel A; Craig RH; Daluge SM; Linden J
    Mol Pharmacol; 1988 Jun; 33(6):585-91. PubMed ID: 3380075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Batrachotoxin changes the properties of the muscarinic receptor in rat brain and heart: possible interaction(s) between muscarinic receptors and sodium channels.
    Cohen-Armon M; Kloog Y; Henis YI; Sokolovsky M
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3524-7. PubMed ID: 2582418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and structural characterization of alpha 1-adrenergic receptor subtypes.
    Terman BI; Riek RP; Grodski A; Hess HJ; Graham RM
    Mol Pharmacol; 1990 Apr; 37(4):526-34. PubMed ID: 2157960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel radioiodinated {gamma}-hydroxybutyric acid analogues for radiolabeling and Photolinking of high-affinity {gamma}-hydroxybutyric acid binding sites.
    Wellendorph P; Høg S; Sabbatini P; Pedersen MH; Martiny L; Knudsen GM; Frølund B; Clausen RP; Bräuner-Osborne H
    J Pharmacol Exp Ther; 2010 Nov; 335(2):458-64. PubMed ID: 20696866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of competition kinetics to investigate rat brain muscarinic receptors.
    Schreiber G; Henis YI; Sokolovsky M
    Isr J Med Sci; 1987; 23(1-2):36-43. PubMed ID: 3570744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and stereochemical requirements for muscarinic receptor binding.
    Aronstam RS; Triggle DJ; Eldefrawi ME
    Mol Pharmacol; 1979 Mar; 15(2):227-34. PubMed ID: 470929
    [No Abstract]   [Full Text] [Related]  

  • 28. Agonist-induced down-regulation of muscarinic cholinergic and alpha 2-adrenergic receptors after inactivation of Ni by pertussis toxin.
    Thomas JM; Hoffman BB
    Endocrinology; 1986 Sep; 119(3):1305-14. PubMed ID: 2426098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
    Tucek S; Musílková J; Nedoma J; Proska J; Shelkovnikov S; Vorlícek J
    Mol Pharmacol; 1990 Nov; 38(5):674-80. PubMed ID: 2233700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscarinic receptor heterogeneity revealed by interaction with bretylium tosylate. Different ligand-receptor conformations versus different receptor subclasses.
    Schreiber G; Sokolovsky M
    Mol Pharmacol; 1985 Jan; 27(1):27-31. PubMed ID: 3965929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin receptor: its subunit structure as determined by photoaffinity labeling.
    Yip CC; Moule ML
    Fed Proc; 1983 Aug; 42(11):2842-5. PubMed ID: 6347720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane.
    Vickroy TW; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1984 Jun; 229(3):747-55. PubMed ID: 6202869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycoprotein nature of dopamine D1 receptors in the brain and parathyroid gland.
    Jarvie KR; Booth G; Brown EM; Niznik HB
    Mol Pharmacol; 1989 Oct; 36(4):566-74. PubMed ID: 2682204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photoaffinity labeling of the brevetoxin receptor on sodium channels in rat brain synaptosomes.
    Trainer VL; Thomsen WJ; Catterall WA; Baden DG
    Mol Pharmacol; 1991 Dec; 40(6):988-94. PubMed ID: 1661842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agonist binding to multiple muscarinic receptors.
    Vickroy TW; Watson M; Yamamura HI; Roeske WR
    Fed Proc; 1984 Oct; 43(13):2785-90. PubMed ID: 6383872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical indentification of the mammalian muscarinic cholinergic receptor.
    Snyder SH; Chang KJ; Kuhar MJ; Yamamura HI
    Fed Proc; 1975 Sep; 34(10):1915-21. PubMed ID: 808430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple distinct subunits of the gamma-aminobutyric acid-A receptor protein show different ligand-binding affinities.
    Bureau M; Olsen RW
    Mol Pharmacol; 1990 Apr; 37(4):497-502. PubMed ID: 2157958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular connectivity study of muscarinic receptor affinity of acetylcholine antagonists.
    Kier LB; Hall LH
    J Pharm Sci; 1978 Oct; 67(10):1408-12. PubMed ID: 702291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conditions for the selective labelling of the 66 000 dalton chain of the acetylcholine receptor by the covalent non-competitive blocker 5-azido-[3H]trimethisoquin.
    Saitoh T; Oswald R; Wennogle LP; Changeux JP
    FEBS Lett; 1980 Jul; 116(1):30-6. PubMed ID: 6893305
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.